Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106298863 | 10629886 | 3 | F | 201410 | 20160906 | 20141205 | 20160920 | EXP | GB-AMGEN-GBRSP2014093936 | AMGEN | 67.00 | YR | E | F | Y | 0.00000 | 20160920 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106298863 | 10629886 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY | N | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||
| 106298863 | 10629886 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG, 2X/WEEK (FOR SEVERAL YEARS) | N | 103795 | 25 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | BIW | |||||
| 106298863 | 10629886 | 3 | SS | ENBREL | ETANERCEPT | 1 | UNK | N | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106298863 | 10629886 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106298863 | 10629886 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106298863 | 10629886 | Lower respiratory tract infection | |
| 106298863 | 10629886 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |